dc.creatorLarrañaga, Carmen
dc.creatorLeón, Oscar
dc.creatorDíaz, Patricia
dc.creatorMiranda, Marta
dc.creatorNorambuena, Ximena
dc.creatorPérez, Marcela
dc.creatorGaggero Brillouet, Aldo
dc.date.accessioned2019-03-11T12:54:55Z
dc.date.available2019-03-11T12:54:55Z
dc.date.created2019-03-11T12:54:55Z
dc.date.issued2007
dc.identifierJournal of Medical Virology, Volumen 79, Issue 12, 2018, Pages 1927-1934
dc.identifier01466615
dc.identifier10969071
dc.identifier10.1002/jmv.21018
dc.identifierhttps://repositorio.uchile.cl/handle/2250/164411
dc.description.abstractParvovirus B19 infection is associated with a wide variety of symptoms and signs, and given that some clinical features, such as anemia, arthropathy and rash may be attributable to other causes, laboratory diagnosis of B19 markers is necessary. The principal aims were to study the behavior of B19 infection-associated diseases in the Chilean population and to compare B19 markers for recent or active infection and for immunity status in patients with clinical symptoms suspicious of B19 infection and control individuals. Sera from a total of 267 patients with diverse clinical manifestations associated with B19 and from 69 healthy controls were tested for B19 DNA using PCR and for specific IgM and immunoglobulin G (IgG) by enzyme-linked immunosorbent assay (ELISA). Out of 267 patients examined, 89 had B19-associated disease markers: 43 had B19 DNA without IgM, 25 had IgM without B19 DNA, and 21 had both B19 DNA and IgM. Also 49 patients were positive only for IgG without B19 DNA or IgM. Ou
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceJournal of Medical Virology
dc.subjectClinical symptoms
dc.subjectParvovirus B19
dc.subjectParvovirus B19 infection markers
dc.titleParvovirus B19 infection in Chile: Markers of infection and immunity in patients with clinical symptoms
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución